U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Conversations on Cancer: Black History Month Program, “Closing Gaps - Building Trust in Clinical Trials for Our Communities” - 02/09/2022
  1. FDA Meetings, Conferences and Workshops

Webcast | Virtual

Event Title
Conversations on Cancer: Black History Month Program, “Closing Gaps - Building Trust in Clinical Trials for Our Communities”
February 9, 2022


Date:
February 9, 2022
Organized By:
Sponsored By:

Twitter:
#ConversationsOnCancer
#BlackFamCan
#OCEProjectCommunity

Featured Speakers:

Wilma Batiste, Community Advisory Board Member, University of California San Francisco, Helen Diller Family Comprehensive Cancer Center | Chairperson, Faith Communities Abundant Life Health Ministries Network | Past Clinical Trial Participant | Health Ministry Leader, Neighborhood Baptist Church, San Francisco

Dr. Hala Borno, Assistant Professor of Medicine at the University of California San Francisco, Co-Medical Director of the Genitourinary Medical Oncology Clinic,  Helen Diller Family Comprehensive Cancer Center

Dr. ‘Lola Fashoyin-Aje, Deputy Division Director & Associate Director, Science & Policy to Address Disparities, Oncology Center of Excellence, FDA

Rudene Haynes, Breast Cancer Survivor | Corporate Finance Lawyer and Partner, Richmond office of Hunton Andrews Kurth LLC | Active in bar, civic, and community initiatives that advance equity | Clinical Trial Participant

Bennette Hooker, Triple Negative Breast Cancer Survivor | Clinical Trial Participant | Breast Cancer and African Americans Program Ambassador, Stanford Cancer Institute

Dr. Richard Pazdur, Director, Oncology Center of Excellence, FDA

Dr. Robert Winn, Director, Virginia Commonwealth University Massey Cancer Center | Elected by the members of Association of American Cancer Institutes to serve as Vice President/President-Elect of AACI’s Board of Directors

Moderator: Rea Blakey, Associate Director for External Outreach and Engagement, Oncology Center of Excellence, FDA

Registration required to attend: https://www.surveymonkey.com/r/Y7QZHRD

Background:

The Oncology Center of Excellence Conversations On Cancer public panel discussion series is observing Black History Month with a distinguished group of National Cancer Institute (NCI)-Designated Cancer Centers and clinical trial trailblazers advancing work in underserved communities. Panelists will address the importance of Community Advisory Boards and the benefit of training non-oncology healthcare professionals and workers. The discussion will also address successful strategies in educating, recruiting and following up with underserved cancer patient populations to inform the advancement of equity in clinical trial participation and associated oncology work.

Webcast

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

Back to Top